Angiogenesis inhibitors: from laboratory to clinical application

Affiliations

Comment

Toshikazu Nakamura et al. Biochem Biophys Res Commun. 2005.

. 2005 Jul 29;333(2):289-91.

doi: 10.1016/j.bbrc.2005.06.001.

¹ Division of Molecular Regenerative Medicine, Osaka University Graduate School of Medicine, Suita, Osaka 565-0871, Japan. nakamura@onbich.med.osaka-u.ac.jp

No abstract available

Comment on

Angioarrestin: a unique angiopoietin-related protein with anti-angiogenic properties.
Dhanabal M, Jeffers M, LaRochelle WJ, Lichenstein HS. Dhanabal M, et al. Biochem Biophys Res Commun. 2005 Jul 29;333(2):308-15. doi: 10.1016/j.bbrc.2005.05.134. Biochem Biophys Res Commun. 2005. PMID: 15950186 Review.
Chondromodulin-I and tenomodulin: a new class of tissue-specific angiogenesis inhibitors found in hypovascular connective tissues.
Shukunami C, Oshima Y, Hiraki Y. Shukunami C, et al. Biochem Biophys Res Commun. 2005 Jul 29;333(2):299-307. doi: 10.1016/j.bbrc.2005.05.133. Biochem Biophys Res Commun. 2005. PMID: 15950187 Review.
Mechanisms and significance of bifunctional NK4 in cancer treatment.
Matsumoto K, Nakamura T. Matsumoto K, et al. Biochem Biophys Res Commun. 2005 Jul 29;333(2):316-27. doi: 10.1016/j.bbrc.2005.05.131. Biochem Biophys Res Commun. 2005. PMID: 15950947 Review.
Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy.
Ferrara N, Hillan KJ, Novotny W. Ferrara N, et al. Biochem Biophys Res Commun. 2005 Jul 29;333(2):328-35. doi: 10.1016/j.bbrc.2005.05.132. Biochem Biophys Res Commun. 2005. PMID: 15961063 Review.
Tumstatin, the NC1 domain of alpha3 chain of type IV collagen, is an endogenous inhibitor of pathological angiogenesis and suppresses tumor growth.
Hamano Y, Kalluri R. Hamano Y, et al. Biochem Biophys Res Commun. 2005 Jul 29;333(2):292-8. doi: 10.1016/j.bbrc.2005.05.130. Biochem Biophys Res Commun. 2005. PMID: 15979458 Review.